ExploreWatchlistsPricing
  1. JP-listed companies
  2. FRONTEO,Inc.
  3. Financials
  4. Revenue

FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 20256,099-17.30%
Mar 31, 20247,375+2.22%
Mar 31, 20237,215-34.00%
Mar 31, 202210,933+5.43%
Mar 31, 202110,370-0.96%
Mar 31, 202010,471-7.03%
Mar 31, 201911,262-7.82%
Mar 31, 201812,218+9.01%
Mar 31, 201711,208+6.20%
Mar 31, 201610,553+68.19%
Mar 31, 20156,274+50.41%
Mar 31, 20144,172-10.86%
Mar 31, 20134,680-8.83%
Mar 31, 20125,133

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat